share_log

一周新股 | 百心安通过聆讯, 卫龙冲刺辣条第一股

New shares of the week | Propranolol passed the hearing, Weilong sprinted the first share of spicy gluten

Moomoo News ·  Nov 13, 2021 05:50

big

This week, the Hang Seng Index rose 0.32% to close at 25327.97.

Hong Kong stock IPO market rebounded this week, a total of 7 new shares delivery table, 2 new shares have been heard, and 3 new shares have been listed.

Weilong Foods, China's leading spicy snack food company, presented its list this week, making it the best-known and most popular spicy snack food brand in China. Weilong ranks first among all spicy snack food companies in China by retail turnover in 2020, with a market share of 5.7%, according to Frost Sullivan.

Baxin, China's leading innovative intrusive cardiovascular device company, passed a hearing this week that its core product, Bioheart ®, is a self-developed BRS system, which is expected to be the first second-generation fully degradable stent system in the world to be regulated based on the results of multicenter randomized controlled clinical trials.

logo

A total of 7 IPOs in the past week:

Weilong foodIs China's leading spicy snack food company, with a strong growth momentum. Weilong ranks first among all spicy snack food companies in China by retail turnover in 2020, with a market share of 5.7%, according to Frost Sullivan.

Weilong is far ahead in brand awareness. It is the most well-known and popular spicy snack food brand in China, and it is also the number one snack food brand in the eyes of young people under the age of 25. According to Frost Sullivan, 95.0% of the company's consumers are 35 and younger, and 55.0% are 25 and younger.

With its ability to expand its category, in recent years, Weilong has successfully expanded to vegetable products and bean products, including "wind eating" and "kiss burning" series and other brands. In 2020, the annual retail sales of the two product categories (namely seasoning noodle products and vegetable products) exceeded 1 billion yuan; among them, the annual retail sales of four products (namely big gluten, konjac Shuang, kiss roast and small gluten) all exceeded 500.0 million yuan.

Weitian ExpressIt is the largest digital freight platform in China, and its platform provides convenient, efficient and standardized full-link digital freight services and solutions for shippers such as logistics companies and shippers, as well as truck drivers. As of June 30, 2021, the company has served more than 8300 shippers and 2 million truck drivers, completing a total of more than 23.2 million shipping orders on the platform.

Fang Zhi developmentIt is one of the mature and comprehensive real estate developers focusing on the economic circle of the Great Bay area, providing high-quality life experience for property buyers by virtue of its brand power and boutique residential properties. Its business activities are mainly concentrated in all parts of the economic circle in the Greater Bay area, especially in the core areas of first-tier, second-tier and selected third-tier cities in the Greater Bay area. The company has a good track record and has been recognized as one of the top 100 Chinese real estate development enterprises in 2021 by China Real Estate Association, Shanghai E-House and China Real Estate Evaluation Center.

Starry ChineseIs the market leader in China's entertainment-related IP industry. In terms of 2020 revenue, the company is the creator and operator of IP, the largest variety festival in China. Star Chinese Holdings has a wide range of popular variety shows IP, including music variety, dance variety, talent variety, talk show, outdoor cultural variety show and other variety shows. The company has launched "The Voice of China", one of the most popular singing competition programs in China, and has also partnered with Youku, one of China's three major online video platforms, to produce the online dance competition program "this!" It's hip-hop.

logo

A total of two new shares have been heard in the past week:

PropranololIs China's leading innovative invasive cardiovascular device company, established in 2014, committed to the development of innovative medical devices to address the unmet medical needs of patients with vascular disease and hypertension in China. The company currently focuses on (I) fully degradable stent (BRS) therapy and (ii) renal nerve occlusion (RDN) therapy. As of the last practical date, Baxin has one core product and eight other pipeline products in different development stages.

Central South ServiceIt is a comprehensive property management service provider in China, deeply ploughing the Yangtze River Delta region and has established a national strategic layout, with steady growth in performance. In 2021, it was rated as the 18th comprehensive strength of China's top 100 property service enterprises by the Middle finger Research Institute. As of September 30, 2021, the company has a total of 215 projects under management, with a total construction area of 4.33 million square meters, covering 65 cities in 19 provinces, municipalities and autonomous regions in China.

logo

There are three new shares listed this week.$an Neng Logistics (09956.HK) $The offering price was set at HK $13.88, the dark market performance closed up 9.51%, and closed down 7.06% as of Friday.

An Neng Logistics operates the largest express network in China. Up to now, the company has gradually set up 151self-operated distribution centers throughout the country, covering more than 2000 inter-provincial direct lines, and has cooperated with about 7000 freight forwarders and 22400 freight forwarders, serving more than 3.6 million end customers. covering about 96% of the counties and townships in China. According to iResearch, the company's market share in terms of total freight volume in 2020 is 17.3%, ranking first in the industry. In addition, the company achieved a gross profit margin of 14.8% in 2020, the highest level of any express network in China.

Edit / Kelly

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment